BioPharmSignal logoBioPharmSignal

Biotech News

LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2026

Lifevantage (LFVN)LifevantageEarnings

Announces New $60 Million Share Repurchase Authorization SALT LAKE CITY, Feb. 04, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial

Related news

LFVNLifevantage2026-05-06 20:05 EST

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

LFVNLifevantage2026-04-22 20:05 EST

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

View all latest news

Lifevantage

Direct-Selling Wellness Company LifeVantage develops and markets nutritional supplements and personal-care products through a network of independent consultants. Nutrigenomics Positioning The company's products are marketed around activation of cellular pathways associated with antioxidant response, metabolism and healthy aging rather...

Recent company news

LFVNLifevantage2026-05-06 20:06 EST

LifeVantage Declares Quarterly Dividend

LFVNLifevantage2026-05-06 20:05 EST

LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026

LFVNLifevantage2026-04-22 20:05 EST

LifeVantage to Announce Third Quarter Fiscal Year 2026 Results on May 6, 2026

LFVNLifevantage2026-04-21 12:00 EST

LifeVantage Receives U.S. Patent for Healthy Glow Essentials Stack

LFVNLifevantage2026-04-20 12:00 EST

LifeVantage Inspires with ‘Breakthrough’ Announcements at 2026 Momentum Academy in Las Vegas

Stock data

Close
6.58 USD
Market cap
108.75M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States